Sign inGet started

Saund Saran

Insider CIK 1834417 · OTLC Chief Business Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
OTLC Oncotelic Therapeutics, In A Award deriv2026-07-102026-07-141,500— $01,500SEC↗
OTLC Oncotelic Therapeutics, In A Award deriv2021-09-032021-09-08675,000— $0675,000SEC↗
OTLC Oncotelic Therapeutics, In A Award deriv2021-07-082021-07-16216,279— $0216,279SEC↗
OTLC Oncotelic Therapeutics, In A Award2021-07-082021-07-16102,519— $016,457,480SEC↗
OTLC Oncotelic Therapeutics, In C Conversion deriv2021-03-312021-07-1616,355— $00SEC↗
OTLC Oncotelic Therapeutics, In C Conversion2021-03-312021-07-1616,354,961— $016,354,961SEC↗